0001104659-11-026870.txt : 20110623 0001104659-11-026870.hdr.sgml : 20110623 20110506164603 ACCESSION NUMBER: 0001104659-11-026870 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20110506 FILER: COMPANY DATA: COMPANY CONFORMED NAME: METABOLIX, INC. CENTRAL INDEX KEY: 0001121702 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS PLASTIC PRODUCTS [3080] IRS NUMBER: 043158289 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 21 ERIE ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-583-1700 MAIL ADDRESS: STREET 1: 21 ERIE ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: METABOLIX INC DATE OF NAME CHANGE: 20000810 CORRESP 1 filename1.htm

 

Metabolix, Inc.

21 Erie Street

Cambridge, MA 02139

 

May 6, 2011

 

Via EDGAR

 

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street N.E.

Washington, D.C. 20549

 

Attention: Sherry Haywood

 

RE:

 

Metabolix, Inc.

 

 

 

Registration Statement on Form S-3

 

 

 

File No. 333-172725

 

 

Ladies and Gentlemen:

 

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Metabolix, Inc. (“Metabolix”) hereby respectfully requests that the effectiveness of the above-referenced registration statement on Form S-3 be accelerated to 4:30 p.m. Eastern Standard Time on May 9, 2011 or as soon as practicable thereafter.

 

Metabolix hereby acknowledges the following:

 

·                  Should the Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;

 

·                  The action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve Metabolix from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and

 

·                  Metabolix may not assert the declaration of effectiveness  as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

 

If you should have any questions regarding this request, please do not hesitate to contact me at (617) 583-1700 or Joseph C. Theis, Esq. (617) 570-1928 of Goodwin Procter LLP.

 

Very truly yours,

 

METABOLIX, INC.

 

 

By:

/s/ Sarah P. Cecil

 

Name:

Sarah P. Cecil, Esq.

 

Title:

General Counsel